Intranigral transplantation of fetal substantia nigra allograft in the hemiparkinsonian rhesus monkey

Cell Transplantation

Volumn 8, Issue 1, 1999, Pages 37-45

  Starr, Philip A ^a   Wichmann, Thomas ^b   Van Horne, Craig ^c   Bakay, Roy A E ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d EMORY CLINIC   (United States)

Author keywords

Fetal cell transplantation; Parkinson's disease; Rhesus monkey; Substantia nigra

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CELL TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; FETUS; LOCOMOTION; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REINNERVATION; RHESUS MONKEY; SUBSTANTIA NIGRA;

ANIMALIA; MACACA MULATTA; PARKINSONIA;

EID: 0032868274     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1177/096368979900800113     Document Type: Article

References (51)

1. Alexander, G. E.; Crutcher, M. D.; DeLong, M. R. Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog. Brain Res. 85:119-146; 1990.
2. Annett, L. E.; Martel, F. L.; Rogers, D. C.; Ridley, R. M.; Baker, H. F.; Dunnett, S. B. Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway. Exp. Neurol. 125:228-246; 1994.
3. Annett, L. E.; Torres, E. M.; Ridley, R. M.; Baker, H. F.; Dunnett, S. B. A comparison of the behavioral effects of embryonic nigral grafts in the caudate nucleus and in the putamen of marmosets with unilateral 6-OHDA lesions. Exp. Brain Res. 103:355-371; 1995.
4. Aziz, T. Z.; Peggs, D.; Sambrook, M. A.; Crossman, A. R. Lesions of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov. Disord. 6:288-292; 1991.
5. Bakay, R. A. E.; Barrow, D. L.; Fiandaca, M. S.; Iuvone, P. M.; Schiff, A.; Collins, D. C. Biochemical and behavioral correction of MPTP Parkinson-like syndrome by fetal cell transplantation. Ann. NY Acad. Sci. 495:623-640; 1987.
6. Bankiewicz, K. S.; Oldfield, E. H.; Chiueh, C. C.; Doppman, J. C.; Jacobowitz, D. M.; Kopin, I. J. Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci. 39:7-16; 1986.
7. Bankiewicz, K. S.; Plunkett, R. J.; Jacobowitz, D. M.; Porrino, L.; DiPorixo, U.; London, W. T.; Koin, I. J.; Oldfield, E. H. The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. J. Neurosurg. 72: 231-244; 1990.
8. Bergman, H.; Wichmann, T.; DeLong, M. R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249:1436-1438; 1990.
9. Bergman, H.; Wichmann, T.; Karmon, B.; DeLong, M. R. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of Parkinsonism. J. Neurophysiol. 72: 507-520; 1994.
10. Bjorklund, A.; Lindvall, O. Dopamine in dendrites of the substantia nigra neurons: Suggestions for a role in dendritic terminals. Brain Res. 83:531-537; 1975.
11. Burns, R. S.; Chiueh, C. C.; Markey, S. P.; Ebert, M. H.; Jacobowitz, D. M.; Kopin, I. J. A primate model of parkinsonisin: Selective destruction of DA neurons in the pars compacta of the substantia nigra by n-methyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80:4546-4550; 1983.
12. Campbell, G. A.; Eckardt, M. J.; Weight, F. F. Dopaminergic mechanisms in subthalamic nucleus of rat: Analysis using horseradish peroxidase and microiontophoresis. Brain Res. 33:261-270; 1985.
13. DeLong, M. R.; Crutcher, M. D.; Georgopoulos, A. P. Relations between movement and single cell discharge in the substantia nigra of the behaving monkey. J. Neurosci. 3: 1599-1606; 1983.
14. Dunnett, S. B.; Bjorklund, A. Neural transplantation: A practical approach. New York: Oxford University Press; 1992.
15. Flores, G.; Valencia, J.; Rosales, M. G.; Sierra, A.; Aceves, J. Appearance of EMG activity and motor asymmetry after unilateral lesions of the dopaminergic innervation to the subthalamic nucleus in the rat. Neurosci. Lett. 162:153-156; 1993.
16. Francois, C.; Savy, C.; Tandé, D.; Yelnik, J. Is there a dopaminergic innervation of the subthalamic nucleus in the primate? Mov. Disord. 13(Suppl. 2):86; 1998 (abstract).
17. Freed, C. R.; Breeze, R. E.; Rosenberg, N. L.; Schneck, S. A.; Kriek, E.; Qi, J.; Lone, T.; Zhang, Y.; Snyder, J. A.; Wells, T. H.; Ramig, L. O.; Thompson, L.; Mazziotta, J. C.; Huang, S. C.; Grafton, S. T.; Brooks, D.; Sawyle, G.; Schroter, G.; Ansari, A. Survival of implanted fetal dopamine cells and neurological improvement 12 to 46 months after transplantation for Parkinson's disease. N. Eng'l. J. Med. 22:1549-1555; 1992.
18. Freeman, T. B.; Olanow, C. W.; Hauser, R. A.; Nauert, G. M.; Smith, D. A.; Borlongan, C. V.; Sanberg, P. R.; Holt, D. A.; Kordower, J. H.; Vingerhoets, F. J. G.; Snow, B. J.; Calne, D.; Gauger, L. L. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann. Neurol. 38:379-388; 1995.
19. Gash, D. M.; Zhang, Z.; Ovadia, A.; Cass, W. A.; Yi, A.; Simmerman, L.; Russell, D.; Martin, D.; Lapchak, P.; Collins, F.; Hoffer, B. J.; Gerhardt, G. A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380:252-255; 1996.
20. Goto, S.; Hirano, A.; Matsumoto, S. Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson's disease and striatonigral degeneration. Ann. Neurol. 26: 766-770; 1989.
21. Guridi, J.; Herrero, M. T.; Luquin, M. R.; Guillen, J.; Ruberg, M.; Laguna, J.; Vila, M.; Javoy-Agid, F.; Agid, Y.; Hirsch, E.; Obeso, J. A. Subthalamotomy in parkinsonian monkeys. Behavioral and biochemical analysis. Brain 119:1717-1727; 1996.
22. Hassani, O. K.; Francois, C.; Yelnik, J.; Feger, J. Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat. Brain Res. 749:88-94; 1997.
23. Henderson, J. M.; Annett, L. E.; Torres, E. M.; Dunnett, S. B. Behavioral effects of subthalamic nucleus lesions in the hemiparkinsonian marmoset (Callithrix jacchus). Eur. J. Neurosci. 689-698; 1998.
24. Hoffman, A. F.; vanHorne, C. G.; Eken, S.; Hoffer, B. J.; Gerhardt, G. A. In vivo microdialysis studies on somatodendritic dopamine release in the rat substantia nigra: Effects of unilateral 6-OHDA lesions and GDNF. Exp. Neurol. 147:130-141; 1997.
25. Johnston, R. E.; Becker, J. B. Intranigral grafts of fetal ventral mesencephalic tissue in adult 6-hydroxydopamine-lesioned rats can induce behavioral recovery. Cell. Transplant. 6:267-276; 1997.
26. Kordower, J. H.; Freeman, T. B.; Snow, B. J.; Vingerhoets, F. J. G.; Mufson, E. J.; Sanberg, P. R.; Hauser, R. A.; Smith, D. A.; Nauert, G. M.; Perl, D. P.; Olanow, C. W. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332:1118-1124; 1995.
27. Lavoie, B.; Smith, Y.; Parent, A. Dopaminergic innervation of the basal ganglia in the squirrel monkey as revealed by tyrosine hydroxylase immunohistochemistry. J. Comp. Neurol. 289:36-52; 1989.
28. Leehey, M. A.; Breeze, R. E.; Schneck, S. A.; O'brien, C. F.; Culver, S.; Thompson, L. L.; McRae, C. A.; Ramig, L. O.; Mazziotta, J. C.; Miletich, R. M.; Eidelberg, D.; Freed, C. R. Neurotransplantation for Parkinson's Disease: Ten years experience. Mov. Disord. 13(Suppl. 2): 278; 1998 (abstract).
29. Magarinos-Ascone, C.; Buno, W.; Garcia-Austt, E. Activity in monkey substantia nigra neurons related to a simple learned movement. Exp. Brain Res. 88:283-291; 1992.
30. Meiback, R. C.; Katzman, R. Catecholaminergic innervation of the subthalamic nucleus: Evidence for a rostral continuation of the A9 (substantia nigra) dopaminergic cell group. Brain Res. 173:364-368; 1979.
31. Nikkhah, G.; Bentlage, C.; Cunningham, M. G.; Bjorklund, A. Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model. J. Neurosci. 14:3449-3461; 1994.
32. Olsson, M.; Nikkhah, G.; Bentlage, C.; Bjorklund, A. Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J. Neurosci. 15:3863-3875; 1995.
33. Peschanski, M.; Defer, G.; N'Guyen, J. P.; Ricolfi, F.; Monfort, J. C.; Remy, P.; Geny, C.; Samson, Y.; Hantraye, P.; Jeny, R.; Gaston, A.; Kéravel, Y.; Degos, J. D.; Cesaro, P. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal tranplantation of foetal ventral mesencephalon. Brain 117:487-499; 1994.
34. Prochiantz, A.; DiPorzio, U.; Kato, A.; Berger, B.; Glowinsky, J. In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in the presence of their striatal target cells. Proc. Natl. Acad. Sci. USA 76:5387-5391; 1979.
35. Redmond, D. E.; Sladek, J. R.; Roth, R. H.; Collier, T. J.; Elsworth, J. D.; Deutch, A. Y.; Haber, S. Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet 8490:1125-1127; 1986.
36. Robertson, G. S.; Damsma, G.; Fibiger, H. C. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats. J. Neurosci. 11: 2209-2216; 1991.
37. Robertson, H. A. Dopamine interactions: Some implications for the treatment of Parkinson's disease. Trends Neurosci. 15:201-206; 1991.
38. Schultz, W. Activity of pars reticulata neurons of monkey substantia nigra in relation to motor, sensory, and complex events. J. Neurophysiol. 4:660-677; 1986.
39. Sladek, J. R.; Redmond, D. E.; Collier, T. J.; Blount, J. P.; Elsworth, J. D.; Taylor, J. R.; Roth, R. H. Fetal dopamine neural grafts: Extended reversal of methylphenyltetrahydropyridine-induced parkinsonism in monkeys. Prog. Brain Res. 78:497-506; 1988.
40. Spencer, D. D.; Robbins, R. J.; Naftolin, F.; Marek, K. L.; Vollmer, T.; Leranth, C.; Roth, R. H.; Price, L. H.; Gjedde, A.; Bunney, B. S.; Sass, K. J.; Elsworth, J. D.; Kier, E. L.; Makuch, R.; Hoffer, P. B.; Redmond, D. E. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's Disease. N. Engl. J. Med. 22:1542-1548; 1992.
41. Starr, M.S. Opposing roles of D-1 and D-2 receptors in nigral GABA release? J. Neurochem. 49:1042-1049; 1987.
42. Stromberg, I.; Bjorklund, A.; Johansson, M.; Tomac, A.; Collins, F.; Olson, L.; Hoffer, B.; Humpel, C. Glial cell line-derived neurotrophic factor is expressed in the developing but not the adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 124:401-412; 1993.
43. Taylor, J. R.; Elsworth, J. D.; Roth, R. H.; Sladek, J. R.; Collier, T. J.; Redmond, D. E. Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: A comparison with other types of grafts as controls. Exp. Brain Res. 85:335-348; 1991.
44. Tomac, A.; Widenfalk, J.; Lin, L. F.; Kohno, T.; Ebendal, T.; Hoffer, B. J.; Olson, L. Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc. Natl. Acad. Sci. USA 92:8274-8278; 1995.
45. Tseng, J. L.; Baetge, E. E.; Zurn, A. D.; Aebischer, P. GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine. J. Neurosci. 17:325-333; 1997.
46. Waszczak, B. E.; Walters, J. R. Endogenous dopamine can modulate inhibition of substantia nigra pars reticulata neurons elicited by GABA iontophoresis or striatal stimulation. J. Neurosci. 6:120-126; 1986.
47. Wenning, G. K.; Odin, P.; Morrish, P.; Rehncrona, S.; Widner, H.; Brundin, P.; Rothwell, J. C.; Brown, R.; Gustavii, B.; Hagell, P.; Jahanshahi, M.; Sawle, G.; Bjorklund, A.; Brooks, D.J.; Marsden, C. D.; Quinn, N. P.; Lindvall, O. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol. 42:95-107; 1997.
48. Wichmann, T.; Bergman, H.; Starr, P. A.; Subramanian, T.; Watts, R. L.; DeLong, M. R. Comparison of MPTP-induced changes in spontanteous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates. Exp. Brain Res. (in press).
49. Wichmann, T.; Kliem, M. A.; DeLong, M. R. Inactivation of the substantia nigra pars reticulata ameliorates parkinsonian signs in MPTP-treated primates. Mov. Disord. 13(Suppl. 2):301; 1998 (abstract).
50. Widner, H.; Tetrud, J.; Rehncrona, S.; Snow, B.; Brundin, P.; Gustavii, B.; Bjorklund, A.; Lindvall, O.; Langston, J. W. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N. Engl. J. Med. 22:1556-1563; 1992.
51. Winters, W. D.; Kado, R. T.; Adey, W. R. A stereotaxic brain atlas for Macaca nemestrina. Berkeley: California Press; 1969.